Description

Docetaxel (Docetaxel) Concentrate for Infusions 20 mg/ml. 1ml. (20 mg.) Vial №1

Ingredients:

Each ml contains 20 mg of Docetaxel.

Dosage:

The dosage of Docetaxel is individualized based on the patient’s condition, weight, and overall health. It is administered intravenously by a healthcare professional.

Indications:

Docetaxel is indicated for the treatment of various types of cancers, including breast cancer, non-small cell lung cancer, prostate cancer, and gastric adenocarcinoma.

Contraindications:

Do not use Docetaxel if you are allergic to docetaxel or any other ingredients in the formulation. It is contraindicated in patients with severely impaired liver function.

Directions:

Administer Docetaxel under the supervision of a qualified healthcare provider experienced in the use of cytotoxic chemotherapy agents. Follow the recommended dosage and infusion guidelines strictly.

Scientific Evidence:

Docetaxel has demonstrated significant efficacy in various clinical trials for the treatment of advanced cancers. Research studies have shown that Docetaxel, as a microtubule inhibitor, disrupts the growth of cancer cells by inhibiting cell division and promoting cell death. This mechanism of action makes it a valuable treatment option in oncology.

Pharmacological Effects:

Docetaxel exerts its pharmacological effects by interfering with microtubule function, leading to cell cycle arrest and apoptosis in cancer cells. This action inhibits the proliferation of cancer cells and ultimately reduces tumor growth. Additionally, Docetaxel has shown anti-angiogenic properties, further suppressing tumor progression.

Clinical Trials and Comparative Effectiveness:

In comparative studies, Docetaxel has demonstrated superior efficacy and tolerability compared to other chemotherapy agents in various cancer types. Clinical trials have highlighted the favorable response rates and survival outcomes associated with Docetaxel, positioning it as a cornerstone in the management of advanced malignancies.

Overall, Docetaxel (Docetaxel) Concentrate for Infusions 20 mg/ml offers a potent therapeutic option for patients battling different types of cancers. Its well-established efficacy, supported by scientific evidence and clinical trials, underscores its importance in modern oncology practice.